Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.

Neill Patani(Institute of Cancer Research), Kefah Mokbel(The Princess Grace Hospital), Wen G. Jiang(Shandong Center for Disease Control and Prevention), Robert F. Newbold(Brunel University of London)
PubMed
December 1, 2011
Cited by 101

Related Papers

SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome
|Nature Genetics|1998|628
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
|Nature|1983|444
The Multiple Sulfatase Deficiency Gene Encodes an Essential and Limiting Factor for the Activity of Sulfatases
|Cell|2003|367
Exceptional mutagenicity of a benzo[a]pyrene diol epoxide in cultured mammalian cells
|Nature|1976|270
Mutagenicity of carcinogenic methylating agents is associated with a specific DNA modification
|Nature|1980|232